compound glp-1 Compounding: When Innovation May Mean Liability What to Expect When Switching
Description
Weight is the primary metric by which anti-obesity drugs are judged and distributed, but weight and BMI are poor measures for visceral fat
PMID: 37288303
Various GLP-1RAs have been demonstrated to have significant benefits in in vitro and in vivo models of neurodegenerative diseases through modulating a variety of pathogenic mechanisms, including neuroinflammation, autophagy, mitochondrial dysfunction, and the abnormal phosphorylation of pathognomonic proteins
Author's Bio: Katie Bailey, MS, RD, LD, FNCHi everyone
Per serving: ~310 cal | 30g protein | 4g fiber
